Overview

Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show that the intake of L-arginine and metformin improves muscle function and delays disease progression in patients with Duchenne's muscular dystrophy.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Treatments:
Metformin